Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness

Diabetes

Volumn 46, Issue 4, 1997, Pages 682-687

  Kogawa, Kyoko ^a   Nishizawa, Yoshiki ^a   Hosoi, Masayuki ^a   Kawagishi, Takahiko ^a   Maekawa, Kiyoshi ^a   Shoji, Tetsuo ^a   Okuno, Yasuhisa ^a   Morii, Hirotoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMORAL ARTERY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INTIMA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING; TUNICA MEDIA; VASCULAR DISEASE;

EID: 0030970819     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.4.682     Document Type: Article

References (35)

1. Colwell JA, Lopes-Virella M, Halushka PV: Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 4:121-133, 1981
2. Garcia MJ, McNamara PM, Gordon T, Kannell WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23:105-111, 1973
3. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548, 1990
4. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H: Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 32:778-781, 1986
5. van Bockxmeer P, Mamotte CD: Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 340:879-880, 1992
6. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD: Relation of apolipoprotein E phenorype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71:160-165, 1993
7. Wang XL, McCredie RM, Wilcken DE: Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 15:1030-1034, 1995
8. van Bockxmeer F, Mamotte CD, Gibbons FR, Taylor RR: Apolipoprotein epsilon 4 homozygosity - a determinant of restenosis after coronary angioplasry. Atherosclerosis 110:195-202, 1994
9. Rigat B, Hubert C, Alhenc GF, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
10. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converring enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
11. Ohishl M, Fujii K, MinaminoT, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T. A potent genetic risk factor for restenosis. Nature Genet 5:324-325, 1993
12. van Bockxmeer F, Mamotte CD, Gibbons FA, Burke V, Taylor RR: Angiotensin-converung enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation 92:2066-2071, 1995
13. Wofford J, Kahl F, Howard G, McKinney W, Toole J, Crouse JI: Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 11:1786-1794, 1991
14. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, Emoto M, Fukumoto S, Shioi A, Shoji T, Inaba M, Okuno Y, Morii H: Angiotensin converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 94:704-707, 1996
15. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P: Insertion/deletion polymorphism of the angiotensin-converung enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
16. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48:820-826, 1995
17. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low lipoprotein in plasma without the use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
18. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidy1 carboxypeptidase 1). Nucleic Adas Res 20:1433, 1992
19. Fujisawa T, Ikegami H, Shen G-Q, Yamato E, Takekawa E, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J, Ohishi M, Fujii K, Fukuda M, Ogihara T: Angiotensin I- converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18:983-985, 1995
20. Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M, Ishii K: Apolipoprotein E polymorphism and hyperlipemia in type n diabetics. Diabetes 35:1374-1382, 1986
21. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, Morishima T, Kamada T Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43:634-639, 1994
22. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17:1330-1336, 1994
23. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21, 1988
24. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F, Fruchart JC, Ducimetiere P: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM Study. Arterioscler Thromb 14:1412-1419, 1994
25. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, Allen A, Karagounis LA, Ward RH: Apolipoprotein polymorphisms fail to define risk of coronary artery disease: results of a prospective, angiographically controlled study. Circulation 89:567-577, 1994
26. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L: European atherosclerosis research study: genotype at the fibrinogen locus (G_455-A β-gene) is associated with differences in plasma fibrinogen level in young men and women from different regions in Europe: evidence for sex-genotype-environment interaction. Arterioscler Thromb Vasc Biol 15:96-104, 1995
27. Schalin-Jantti C, Nikula-Ijas P, Huang X, Lehto M, Knudsen P, Syvanne M, Lehtovirta MT, Tikkanen I, Groop LC: Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects. Hypertension 27:67-71, 1996
28. Castellano M, Muiesan M, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M, Porten E, Betoni G, Kreutz R, Lindpaintner K, Rosei E: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population: the Vobarno study. Circulation 91:2721-2724, 1995
29. Sternby N: Atherosclerosis in a defined population: an autopsy survey in MalmØ, Sweden. Acta Pathol Microbiol Scand 194 (Suppl. I):111-118, 1968
30. Wendelhag I, Wlklund O, Wlkstrand J: Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: ultrasonographic assessment of intima-medla thickness and plaque occurrence. Arterioscler Thromb 13:1404-1411, 1993
31. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
32. Danser A, Schalekamp M, Bax W, van den Brink A, Saxena P, Riegger G, Schunkert H: Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
33. Johnston C: Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23:258-268, 1994
34. Cooper M, Rumble J, Komers R, He-Cheng D, Jandeleit K, Sheung-To C: Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes 43:1221-1228, 1994
35. Bonithon KC, Ducimetiere P, Touboul PJ, Feve JM, Billaud E, Courbon D, Heraud V: Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 89:952-954, 1994